Precigen, Inc. Research and Development (R&D) Expenses Growth

Research and Development (R&D) Expenses Growth of PGEN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Research and Development (R&D) Expenses Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Research and Development (R&D) Expenses Growth for the quarter ending June 30, 2022 was -12.62% (a -159.3% decrease compared to previous quarter)
  • Year-over-year quarterly Research and Development (R&D) Expenses Growth decreased by -146.71%
  • Annual Research and Development (R&D) Expenses Growth for 2021 was 20.4% (a -154.36% decrease from previous year)
  • Annual Research and Development (R&D) Expenses Growth for 2020 was -37.53% (a -54.12% decrease from previous year)
  • Annual Research and Development (R&D) Expenses Growth for 2019 was -81.8% (a -152.52% decrease from previous year)
  • Twelve month Research and Development (R&D) Expenses Growth ending June 30, 2022 was 12.45% (a -55.94% decrease compared to previous quarter)
  • Twelve month trailing Research and Development (R&D) Expenses Growth decreased by -93.25% year-over-year
Trailing Research and Development (R&D) Expenses Growth for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
12.45% 28.26% 20.4% 184.57%
Visit stockrow.com/PGEN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Research and Development (R&D) Expenses Growth of Precigen, Inc.

Most recent Research and Development (R&D) Expenses Growthof PGEN including historical data for past 10 years.

Interactive Chart of Research and Development (R&D) Expenses Growth of Precigen, Inc.

Precigen, Inc. Research and Development (R&D) Expenses Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -12.62% 21.28%
2021 22.0% 27.02% 44.41% -7.12% 20.4%
2020 175.26% -60.37% -66.45% -57.95% -37.53%
2019 -106.79% -42.82% -32.84% -27.72% -81.8%
2018 4526.77% 23.07% 23.63% 9.03% 155.75%
2017 -84.37% 25.61% 19.86% 32.19% 27.71%
2016 10.2% 34.43% 39.22% -67.4% -23.97%
2015 48.51% 45.43% 41.2% 557.71% 150.04%
2014 40.56% 39.16% 6.84% 5.67% 22.52%
2013 -12.63% -39.5% -6.4% -5.37% -24.82%
2012 14.45% 65.3% -8.82%
2011 9.67%

Business Profile of Precigen, Inc.

Sector: Healthcare
Industry: Biotechnology